Page last updated: 2024-09-02

triptolide and Encephalitis

triptolide has been researched along with Encephalitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, Y; Hu, X; Jin, X; Li, J; Shi, J; Zhang, C; Zhang, T; Zhao, J1
Li, F; Lu, L; Wang, X1
Cai, DF; Chen, YP; Gao, JP; Li, WW; Sun, S1

Reviews

1 review(s) available for triptolide and Encephalitis

ArticleYear
Novel anti-inflammatory and neuroprotective agents for Parkinson's disease.
    CNS & neurological disorders drug targets, 2010, Volume: 9, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Brain; Cytoprotection; Diterpenes; Encephalitis; Epoxy Compounds; Glatiramer Acetate; Humans; Microglia; Minocycline; Neuroprotective Agents; Parkinson Disease; Peptides; Phenanthrenes

2010

Other Studies

2 other study(ies) available for triptolide and Encephalitis

ArticleYear
The novel and potent anti-depressive action of triptolide and its influences on hippocampal neuroinflammation in a rat model of depression comorbidity of chronic pain.
    Brain, behavior, and immunity, 2017, Volume: 64

    Topics: Analgesics; Animals; Antidepressive Agents; Behavior, Animal; Chronic Pain; Depression; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Encephalitis; Epoxy Compounds; Fluoxetine; Hippocampus; Hyperalgesia; Inflammation Mediators; Male; Microglia; Phenanthrenes; Rats, Sprague-Dawley

2017
Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson's disease.
    Neuroscience bulletin, 2008, Volume: 24, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Biomarkers; CD11b Antigen; Cell Count; Cell Survival; Disability Evaluation; Diterpenes; Dopamine; Encephalitis; Epoxy Compounds; Gliosis; Herbicides; Immunosuppression Therapy; Immunosuppressive Agents; Male; Microglia; Neurons; Parkinsonian Disorders; Phenanthrenes; Rats; Rats, Sprague-Dawley; Substantia Nigra; Treatment Outcome; Tyrosine 3-Monooxygenase

2008